The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer [seen in some human studies]:
http://www.biosciencetechnology.com/New ... ongoing-s/
If shown to be true, the risk in feline diabetics would remain unknown. As there is no feline insulin available, all insulins for treatment of feline diabetes carry some potential risk. High circulating levels of insulin are associated with cancer in humans, and (not surprisingly) high-carbohydrate diets are linked with cancer.
There are more questions than answers...
-Craig
http://www.biosciencetechnology.com/New ... ongoing-s/
If shown to be true, the risk in feline diabetics would remain unknown. As there is no feline insulin available, all insulins for treatment of feline diabetes carry some potential risk. High circulating levels of insulin are associated with cancer in humans, and (not surprisingly) high-carbohydrate diets are linked with cancer.
There are more questions than answers...
-Craig